B S Scientific Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-11-2024
- Paid Up Capital ₹ 0.10 M
as on 02-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 02-11-2024
- Revenue 21.05%
(FY 2023)
- Profit 24.37%
(FY 2023)
- Ebitda 113.65%
(FY 2023)
- Net Worth 64.44%
(FY 2023)
- Total Assets 14.62%
(FY 2023)
About B S Scientific
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Manoj Sinha, Binita Sinha, Sandeep Sinha, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300UP2021PTC141142
- Company No.
141142
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at B S Scientific?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Sinha  | Additional Director | 09-Nov-2021 | Current |
| Piyush Choudhary | Additional Director | 09-Nov-2021 | Current |
| Manoj Sinha | Director | 02-Feb-2021 | Current |
| Binita Sinha | Director | 02-Feb-2021 | Current |
Financial Performance of B S Scientific.
B S Scientific Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.05% increase. The company also saw a substantial improvement in profitability, with a 24.37% increase in profit. The company's net worth Soared by an impressive increase of 64.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B S Scientific?
Unlock access to B S Scientific's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2023 | Others | ₹1.00 M | Open |
How Many Employees Work at B S Scientific?
B S Scientific has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B S Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B S Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
